1.270USD-3.79%Mkt Cap: 104.49M USDP/E: —Last update: 2026-06-01
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), c…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap104.49M USD
Enterprise Value78.79M USD
Revenue (TTM)0 USD
Gross Profit-54.21M USD
Net Income (TTM)-84.95M USD
Revenue/Share0.0000 USD
Last Price1.270 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees112
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS45773H2013
Valuation
P/E (Trailing)—
P/E (Forward)-2.33
PEG—
EV/EBITDA-0.96
EV/Revenue—
P/SInfinity
P/B3.75
EPS (TTM)-1.58
EPS (Forward)-0.56
52W Range
1.03012% of range2.980
52W High2.980 USD
52W Low1.030 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin-130000.00%
ROE-352.53%
ROA-114.31%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-88.63M USD
CapEx (TTM)285.70K USD
FCF Margin—
FCF Yield-32.32%
Net Debt-28.99M USD
Net Debt/EBITDA0.35
Balance Sheet
Debt/Equity0.39
Current Ratio1.04
Quick Ratio0.99
Book Value/Sh0.3490 USD
Cash/Share0.4580 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:12
Split DateJan 25, 2024
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)5.960 USD
Target Range1.800 USD – 13.00 USD
# Analysts5
Ownership
Shares Out.82.27M
Float81.93M
Insiders0.42%
Institutions47.30%
Short Interest
Short Ratio4.6d
Short % Float22.17%
Short % Out.19.42%
Shares Short15.98M
Short (prev mo.)12.77M
Technical
SMA 501.298 (-2.2%)
SMA 2001.851 (-31.4%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)3.12M
Avg Vol (10d)2.88M
Technical Indicators
RSI (14)52.9
MACD0.0073
MACD Signal0.0029
MACD Hist.+0.0044
BB Upper1.486 USD
BB Middle1.291 USD
BB Lower1.095 USD
BB Width30.28%
ATR (14)0.1148 USD
Vol Ratio (20d)0.23x